Rhythm Pharmaceuticals (RYTM) P/E Ratio
P/E Ratio as of Jun 16, 2025: -22.16
Average-22.48
Median-22.34
Minimum-24.19
Maximum-21.02
-22.16
Past Month-0.78 (3.65%)
The P/E ratio for Rhythm Pharmaceuticals (RYTM) is -22.16 as of Jun 16, 2025. This represents a increase of 69.94% compared to its 12-month average P/E ratio of -13.04. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Rhythm Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Rhythm Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Rhythm Pharmaceuticals to industry peers.
Rhythm Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Rhythm Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Rhythm Pharmaceuticals to industry peers.
Rhythm Pharmaceuticals (RYTM) P/E Ratio Insights
See Rhythm Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Rhythm Pharmaceuticals (RYTM)
Order type
Buy in
Order amount
Est. shares
0 shares
Rhythm Pharmaceuticals (RYTM) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $63.66 | -22.61 |
| May 1, 2025 | $63.80 | -14.63 |
| Apr 1, 2025 | $50.00 | -11.47 |
| Mar 3, 2025 | $52.40 | -12.02 |
| Feb 3, 2025 | $59.41 | -13.69 |
| Jan 2, 2025 | $60.07 | -13.85 |
Rhythm Pharmaceuticals (RYTM) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -22.16 | +71.78% |
| 2024 | -12.90 | -8.51% |
| 2023 | -14.10 | +73.86% |
| 2022 | -8.11 | +10.04% |
| 2021 | -7.37 | -24.72% |
| 2020 | -9.79 | — |
FAQs About Rhythm Pharmaceuticals (RYTM) P/E ratio
The latest P/E ratio of Rhythm Pharmaceuticals (RYTM) is -22.16, as of Jun 16, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Rhythm Pharmaceuticals’s last 12-month average P/E ratio is -13.04, compared to its current P/E ratio of -22.16. This reflects a increase of 69.94%.
Rhythm Pharmaceuticals’s current P/E ratio of -22.16 is higher than its last 12-month average P/E of -13.04. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Rhythm Pharmaceuticals’s average P/E ratio over the last 3 years is -9.54. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Rhythm Pharmaceuticals’s average P/E ratio over the last 5 years is -9.27. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.